Veeva Systems

LEO Pharma Connects Affiliates with Veeva Vault Safety to Transform Safety Operations

Retrieved on: 
Tuesday, October 3, 2023
Cloud, Drug development, Leo Pharma, Pharmacovigilance, Safety, Veeva Systems, Patient, Case management, NYSE, Pharmaceutical industry

BARCELONA, Spain, Oct. 3, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that LEO Pharma, a global leader in medical dermatology, is using Veeva Vault Safety to optimize its safety operations. With this foundation, the company can seamlessly incorporate affiliates into safety workflows, boost operational efficiencies, ensure compliance, and unify its global pharmacovigilance data on one platform.

Key Points: 
  • BARCELONA, Spain, Oct. 3, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that LEO Pharma , a global leader in medical dermatology, is using Veeva Vault Safety to optimize its safety operations.
  • "LEO Pharma is deeply committed to the safety of patients using its products," said Pilar Carrero, vice president of global safety at LEO Pharma.
  • Vault Safety is helping LEO Pharma improve oversight of case intake, processing, submission, and distribution while simplifying safety workflows and eliminating data reconciliation with affiliates and partners.
  • "Veeva is happy to partner with LEO Pharma to make its safety operations simpler and more effective."

palleos healthcare Advances Clinical Trial Execution with Veeva Vault Clinical Data Applications

Retrieved on: 
Thursday, September 21, 2023
Cloud, Health status of Asian Americans, Vault, Trial of the century, Thought, Organization, Veeva Systems, CDMS, Patient, NYSE, Safety, Pharmaceutical industry

BARCELONA, Spain, Sept. 21, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that palleos healthcare has selected Veeva Vault Clinical Data Management Suite (CDMS) with Veeva Vault EDC and Veeva CDB (clinical database) to connect all clinical study data on one platform. A unified view of clinical data from wearables and other sources offers palleos healthcare greater visibility and control to adapt studies in real time.

Key Points: 
  • BARCELONA, Spain, Sept. 21, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that palleos healthcare has selected Veeva Vault Clinical Data Management Suite (CDMS) with Veeva Vault EDC and Veeva CDB (clinical database) to connect all clinical study data on one platform.
  • A unified view of clinical data from wearables and other sources offers palleos healthcare greater visibility and control to adapt studies in real time.
  • "Unifying data with Veeva Vault EDC and Veeva CDB gives palleos healthcare real-time insight into how a study is progressing, enabling us to better assess and manage outcomes."
  • "Veeva Vault EDC and Veeva CDB offer palleos healthcare a comprehensive view of their study data, enabling them to further advance clinical trial execution to benefit patients."

LTS Advances Quality Oversight with Veeva Vault QMS

Retrieved on: 
Thursday, September 14, 2023
CREATE, Administration, Research, Veeva Systems, CARE, Patient, GxP, LTS, NYSE, Audit, Medical device

BARCELONA, Spain, Sept. 14, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company, is partnering with Veeva MedTech to advance its quality operations. LTS will use Veeva Vault QMS to improve process control and visibility, align global production sites, and increase audit readiness.

Key Points: 
  • LTS will use Veeva Vault QMS to improve process control and visibility, align global production sites, and increase audit readiness.
  • "With Veeva Vault QMS, we will strengthen oversight and GxP compliance while aligning with the quality requirements of our customers."
  • "Veeva Vault QMS helps companies like LTS simplify quality processes for better efficiency while ensuring ongoing inspection readiness," said Patrik Brehm, director of quality strategy for Veeva MedTech in Europe.
  • Vault QMS is part of Vault Quality Suite , which brings together quality systems and processes on a single cloud platform to enable efficient quality management.

Veeva Introduces Study Portal and VeevaID to Streamline Research Site Trial Execution

Retrieved on: 
Wednesday, September 13, 2023
Fourth Estate Public Benefit Corporation, PBC, Professional corporation, Clinical trial, PT, Health, NYSE, Online shopping, Veeva Systems

PLEASANTON, Calif., Sept. 13, 2023 /PRNewswire/ -- 2023 Veeva R&D and Quality Summit, North America -- Veeva Systems (NYSE: VEEV) today announced Veeva Study Portal, a free cloud application to simplify research site access to sponsor technologies. Study Portal will make it easy for clinical researchers to create and share study profiles containing links to all the relevant sponsor technology systems used for a clinical trial. Users will be able to securely store their individual usernames and passwords with the study profile rather than managing multiple links, usernames, and passwords on sticky notes or spreadsheets. Study Portal will work with all sponsor technology systems.

Key Points: 
  • PLEASANTON, Calif., Sept. 13, 2023 /PRNewswire/ -- 2023 Veeva R&D and Quality Summit, North America -- Veeva Systems (NYSE: VEEV) today announced Veeva Study Portal , a free cloud application to simplify research site access to sponsor technologies.
  • Study Portal will make it easy for clinical researchers to create and share study profiles containing links to all the relevant sponsor technology systems used for a clinical trial.
  • In addition to Study Portal, Veeva announced VeevaID to provide single sign-on for clinical researchers across all sponsor systems, such as Veeva Vault EDC , Veeva Vault Study Training , and Veeva RTSM .
  • Veeva Study Portal and VeevaID are planned for availability in December 2023.

New Batch Release Application for Life Sciences Manufacturing to Speed Time-to-Market and Reduce Cost

Retrieved on: 
Wednesday, September 13, 2023
GMP, QMS, ERP, Haleon, Quality control, LIMS, Health, NYSE, Locksmithing, Veeva Systems

PLEASANTON, Calif., Sept. 13, 2023 /PRNewswire/ -- 2023 Veeva R&D and Quality Summit, North America -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault Batch Release, a new cloud application that will enable faster, more confident GMP release and market-ship decisions. Vault Batch Release addresses increased manufacturing and supply chain complexity by streamlining the aggregation and review of data and content while simplifying collaboration with external partners.

Key Points: 
  • Vault Batch Release addresses increased manufacturing and supply chain complexity by streamlining the aggregation and review of data and content while simplifying collaboration with external partners.
  • "Veeva Vault Batch Release will offer an automated, end-to-end solution for an underserved, complex process with compliance and cost risk," said Mike Jovanis, vice president of quality and manufacturing at Veeva.
  • Vault Batch Release will bring together data and content across QMS, LIMS, ERP, and regulatory systems for real-time visibility into batch release status.
  • By connecting systems and automating data aggregation, reviews, and traceability, Vault Batch Release can improve efficiency and speed time to market.

Veeva Introduces Study Portal and VeevaID to Streamline Research Site Trial Execution

Retrieved on: 
Wednesday, September 13, 2023
Fourth Estate Public Benefit Corporation, PBC, Professional corporation, Clinical trial, PT, Health, NYSE, Online shopping, Veeva Systems

BARCELONA, Spain, Sept. 13, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Study Portal, a free cloud application to simplify research site access to sponsor technologies. Study Portal will make it easy for clinical researchers to create and share study profiles containing links to all the relevant sponsor technology systems used for a clinical trial. Users will be able to securely store their individual usernames and passwords with the study profile rather than managing multiple links, usernames, and passwords on sticky notes or spreadsheets. Study Portal will work with all sponsor technology systems.

Key Points: 
  • BARCELONA, Spain, Sept. 13, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Study Portal , a free cloud application to simplify research site access to sponsor technologies.
  • Study Portal will make it easy for clinical researchers to create and share study profiles containing links to all the relevant sponsor technology systems used for a clinical trial.
  • In addition to Study Portal, Veeva announced VeevaID to provide single sign-on for clinical researchers across all sponsor systems, such as Veeva Vault EDC , Veeva Vault Study Training , and Veeva RTSM .
  • Veeva Study Portal and VeevaID are planned for availability in December 2023.

New Batch Release Application for Life Sciences Manufacturing to Speed Time-to-Market and Reduce Cost

Retrieved on: 
Wednesday, September 13, 2023
GMP, QMS, ERP, Haleon, Quality control, LIMS, Health, NYSE, Locksmithing, Veeva Systems

BARCELONA, Spain, Sept. 13, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault Batch Release, a new cloud application that will enable faster, more confident GMP release and market-ship decisions. Vault Batch Release addresses increased manufacturing and supply chain complexity by streamlining the aggregation and review of data and content while simplifying collaboration with external partners.

Key Points: 
  • Vault Batch Release addresses increased manufacturing and supply chain complexity by streamlining the aggregation and review of data and content while simplifying collaboration with external partners.
  • "Veeva Vault Batch Release will offer an automated, end-to-end solution for an underserved, complex process with compliance and cost risk," said Mike Jovanis, vice president of quality and manufacturing at Veeva.
  • Vault Batch Release will bring together data and content across QMS, LIMS, ERP, and regulatory systems for real-time visibility into batch release status.
  • By connecting systems and automating data aggregation, reviews, and traceability, Vault Batch Release can improve efficiency and speed time to market.

Veeva to Present at Upcoming Investor Conference

Retrieved on: 
Friday, September 1, 2023
Veeva Systems, Conference, NYSE, Cryptocurrency

PLEASANTON, Calif., Sept. 1, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference:

Key Points: 
  • PLEASANTON, Calif., Sept. 1, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference:
    Citi 2023 Global Technology Conference, New York, NY.
  • Paul Shawah, EVP Commercial Strategy, is presenting on Wednesday, September 6, 2023, at 1:00 p.m. Eastern Time.
  • The above presentation will be webcast.
  • Links to the live and archived webcast will be available on Veeva's investor relations website at https://ir.veeva.com .

Veeva Clinical Database Crosses 200 Study Milestone, Cuts Time to Aggregate and Clean Study Data by 30-50%

Retrieved on: 
Thursday, August 31, 2023
Data management, American Opportunity Tax Credit, Clinical trial, Medidata Solutions, NYSE, CDB, ChromeOS, EDC, Medical imaging, Veeva Systems

PLEASANTON, Calif., Aug. 31, 2023 /PRNewswire/ -- Veeva Clinical Database (CDB) enables innovative ways of managing clinical trial data, saving customers 30 to 50% of the time required to aggregate, clean, and transform data. Since Veeva Systems (NYSE: VEEV) announced its launch, Veeva CDB has cleaned more than 200,000 subjects to quickly provide quality data across more than 200 studies.

Key Points: 
  • "By launching Veeva CDB and building processes around it, we're laying a foundation for clinical data transformation," said Jerry Yarem, vice president, data management, Fortrea.
  • In addition, the Veeva CDB Data Provider Program enables qualified partners with resources to gain operational efficiencies when delivering data for Veeva CDB customers.
  • "With more than 30 data providers supplying study data, Veeva CDB is gaining momentum, advancing clinical data management for seamless information exchange and faster access to high-quality data."
  • For more on Veeva CDB, visit: veeva.com/VeevaCDB
    For more on Veeva CDB Data Provider Program, visit: veeva.com/CDBdataprovider Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

Veeva Clinical Database Crosses 200 Study Milestone, Cuts Time to Aggregate and Clean Study Data by 30-50%

Retrieved on: 
Thursday, August 31, 2023
Data management, American Opportunity Tax Credit, Clinical trial, Medidata Solutions, NYSE, CDB, ChromeOS, EDC, Medical imaging, Veeva Systems

BARCELONA, Spain, Aug. 31, 2023 /PRNewswire/ -- Veeva Clinical Database (CDB) enables innovative ways of managing clinical trial data, saving customers 30 to 50% of the time required to aggregate, clean, and transform data. Since Veeva Systems (NYSE: VEEV) announced its launch, Veeva CDB has cleaned more than 200,000 subjects to quickly provide quality data across more than 200 studies.

Key Points: 
  • "By launching Veeva CDB and building processes around it, we're laying a foundation for clinical data transformation," said Jerry Yarem, vice president, data management, Fortrea.
  • In addition, the Veeva CDB Data Provider Program enables qualified partners with resources to gain operational efficiencies when delivering data for Veeva CDB customers.
  • "With more than 30 data providers supplying study data, Veeva CDB is gaining momentum, advancing clinical data management for seamless information exchange and faster access to high-quality data."
  • For more on Veeva CDB, visit: veeva.com/VeevaCDB
    For more on Veeva CDB Data Provider Program, visit: veeva.com/CDBdataprovider
    Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems